HLA-B27 Positive Diet Chart: Evidence-Graded Guide

An HLA-B27 diet chart should start with an honest fact: no food changes the HLA-B27 gene, and no diet has been shown to prevent HLA-B27 disease in healthy carriers. For people already diagnosed with an HLA-B27 associated spondyloarthritis, the evidence supports a short list of changes. Weight loss improves psoriatic arthritis activity (Klingberg et al., 2019; Di Minno et al., 2014). High-dose omega-3 lowered ankylosing spondylitis activity in a small randomized trial (Sundström et al., 2006). Closer adherence to a Mediterranean diet tracked with lower disease activity in axial spondyloarthritis (Ometto et al., 2021). The 2021 EULAR lifestyle recommendations add a sobering line: specific food types are unlikely to have large benefits for rheumatic disease outcomes (Gwinnutt et al., 2023). The chart below grades every item A, B or C so you can tell solid ground from hopeful guesswork.

This guide covers the whole HLA-B27 spectrum. For the ankylosing spondylitis menu in depth, see our ankylosing spondylitis diet guide. For the full case for and against starch restriction, see our London diet deep-dive.

What Is HLA-B27?

HLA-B27 is one version of a gene in the human leukocyte antigen (HLA) system, the set of genes that help the immune system tell self from non-self. The HLA-B27 protein sits on the surface of nearly every cell and displays small protein fragments to T cells. When a T cell recognizes a fragment as foreign, it raises the alarm.

The variant is common. In the first national US study, based on DNA testing of 2,320 adults in NHANES 2009, age-adjusted HLA-B27 prevalence was 6.1% (Reveille et al., 2012). It was 7.5% in non-Hispanic white adults, 4.6% in Mexican Americans and 1.1% in non-Hispanic Black adults. Men and women carried it at similar rates.

The disease link is strong. Between 85% and 95% of people with ankylosing spondylitis carry HLA-B27, against roughly 8% of the general population in the European cohorts studied (van der Linden et al., 2022). Yet HLA-B27 explains only about 20% of the heritability of AS. Dozens of other genes, gut bacteria and environmental triggers fill in the rest.

What a Positive HLA-B27 Test Means

A positive test tells your doctor that a spondyloarthritis diagnosis is more likely if you already have suggestive symptoms. It does not diagnose anything on its own. Most carriers live their entire lives without joint or eye disease.

The numbers differ because the studies asked different questions. An earlier Dutch family study put the rate of classic ankylosing spondylitis among HLA-B27 positive adults in the general population at 1.3% (cited in van der Linden et al., 2022). When Braun and colleagues screened Berlin blood donors with questionnaires, exams and sacroiliac MRI, 19 of 140 HLA-B27 positive donors (13.6%) had some form of spondyloarthritis, much of it mild or undiagnosed, against 1 of 133 HLA-B27 negative donors (Braun et al., 1998). Family history changes the picture most: in a 35-year Swiss family study, 48 of 177 HLA-B27 positive first-degree relatives of AS patients (27.1%) developed axial spondyloarthritis, against 1.6% of HLA-B27 negative relatives (van der Linden et al., 2022).

Conditions Linked to HLA-B27

HLA-B27 is the shared thread in a family of diseases called the spondyloarthritides (or spondyloarthropathies). They overlap in symptoms, often run in the same families and respond to many of the same drugs.

Uveitis deserves special attention. Roughly 50% of all people with acute anterior uveitis are HLA-B27 positive, and in a UK cohort of more than 2,000 axSpA patients, 23.5% reported at least one episode (Wakefield et al., 2020). It can come before any back pain. A red, painful, light-sensitive eye needs a same-day eye exam, not a diet change.

HLA-B27 and the Gut: What the Research Shows

The strongest reason to think about diet at all is that HLA-B27 disease appears to begin, at least partly, in the gut. Three lines of evidence point that way.

Germ-Free Rats Do Not Get Gut or Joint Disease

In 1990, Hammer and colleagues created rats carrying human HLA-B27 and human beta-2 microglobulin. One high-expressing line spontaneously developed inflammation of the gut, peripheral and spinal joints, male genital tract, skin, nails and heart, a pattern strikingly close to human spondyloarthritis (Hammer et al., 1990).

Four years later the same group raised these rats in a germ-free environment. Without gut bacteria, the rats did not develop intestinal or peripheral joint inflammation, although skin and genital lesions still appeared (Taurog et al., 1994). The gene alone was not enough. Commensal bacteria were required.

Protein Misfolding and the IL-23/IL-17 Axis

The HLA-B27 heavy chain has an unusual tendency to misfold inside the endoplasmic reticulum, the cell's protein-folding factory. Misfolded chains pile up, bind the chaperone BiP and can trigger the unfolded protein response, a cellular stress program (Colbert et al., 2009). In transgenic rats, misfolding and the unfolded protein response augmented IL-23 production and were associated with Th17 activation (DeLay et al., 2009).

Human data complicate the story. In gut biopsies from 30 HLA-B27 positive AS patients, Ciccia and colleagues found signs of misfolded heavy chains but no significant overexpression of unfolded protein response genes. Autophagy, a cellular recycling pathway, appeared to drive IL-23 instead (Ciccia et al., 2014). The exact intracellular route is still debated.

The downstream target is not in doubt. Blocking IL-17A with secukinumab reduced AS signs and symptoms in two phase 3 trials, MEASURE 1 (371 patients) and MEASURE 2 (219 patients) (Baeten et al., 2015). IL-17 and TNF inhibitors are now standard AS drugs, which confirms that the IL-23/IL-17 pathway carries real clinical weight.

HLA-B27 Shapes the Gut Microbiome, Even in Healthy People

Terminal ileum biopsies from recent-onset, TNF-inhibitor-naive AS patients carry a distinct bacterial signature compared with healthy controls (Costello et al., 2015). The obvious question is whether disease changes the bacteria or the bacteria help cause disease.

Asquith and colleagues tackled that by studying healthy people. In 568 samples from six gut sites in 107 healthy volunteers, plus stool from 696 TwinsUK twin pairs, carrying HLA-B27 was associated with differences in overall gut microbial composition (Asquith et al., 2019). Some of the dysbiosis seen in AS is therefore at least partly a product of host genetics, present before any disease.

Where Klebsiella Fits

Alan Ebringer's group proposed that Klebsiella pneumoniae, a starch-fermenting gut bacterium, carries molecules that resemble HLA-B27, so immune responses against Klebsiella cross-react with the body's own tissue (Ebringer and Wilson, 1996). That idea is the basis of the low-starch diet. It has supporters and detractors, and no large trial has settled it. Our London diet article covers the hypothesis and the counter-arguments in detail.

What Diet Evidence Exists Across the Spondyloarthritis Spectrum

The honest summary is short. A 2018 systematic review of 16 studies on diet and ankylosing spondylitis called the evidence "extremely limited and inconclusive," mostly small single studies with moderate-to-high risk of bias (Macfarlane et al., 2018). A 2025 systematic review of 49 randomized trials across RA, axSpA and PsA found evidence in axSpA limited, with possible benefit from omega-3 fatty acids, and found calorie restriction plus omega-3 linked to lower activity in PsA (Van den Bruel et al., 2025).

EULAR's 2021 lifestyle task force went further. Its diet recommendations state that a healthy, balanced diet is integral to lifestyle improvement, and that people with rheumatic and musculoskeletal diseases "should be informed that consuming specific food types is unlikely to have large benefits" for their disease, a statement rated at the top level of evidence (Gwinnutt et al., 2023). The same task force backed controlled, intentional weight loss for people who are overweight.

So the chart below leans on two tested levers, weight and omega-3, and treats everything else as a structured personal experiment.

Axial Spondyloarthritis Diet (AS and Non-Radiographic axSpA)

Omega-3 fatty acids: Grade B. Sundström and colleagues randomized 24 AS patients to 1.95 g or 4.55 g of omega-3 daily for 21 weeks. In the 18 completers, the high-dose group showed a significant fall in BASDAI disease activity (p = 0.038); the low-dose group did not (Sundström et al., 2006). The trial was tiny and had no placebo arm, but it fits the 2025 review's signal.

Mediterranean pattern: Grade C. In an Italian cohort of 161 axSpA patients, 81 received six months of nutritionist advice based on the Mediterranean diet. A 20% or greater improvement in PREDIMED adherence score was associated with a 20% or greater improvement in ASDAS-CRP (odds ratio 6.75, 95% CI 1.8 to 25.3) (Ometto et al., 2021). Patients with psoriasis and longer disease duration seemed to gain less.

Dietary fiber: Grade C. Among 165 AS patients in China, those eating more than 25 g of fiber a day had lower ASDAS-CRP and BASDAI scores, with or without bowel symptoms (Song et al., 2023). This is a cross-sectional association, so causation is unproven.

Weight: Grade B. In 155 AS patients starting infliximab, a higher BMI predicted a weaker response. BASDAI50 response fell from 77.6% in normal-weight patients to 26.5% in obese patients (Ottaviani et al., 2012). Weight loss trials in AS are lacking, so the grade borrows from the PsA data below.

Low starch: Grade C. Thirty-six AS patients on a low-starch diet for about nine months showed falls in ESR and total IgA, with most reporting fewer symptoms (Ebringer and Wilson, 1996). There was no control group. The full menu and protocol live in our ankylosing spondylitis diet guide; exercise, supplements and drug context are in our ankylosing spondylitis natural treatment guide.

Psoriatic Arthritis Diet

PsA has the best diet data in the spondyloarthritis family, and nearly all of it concerns body weight.

Weight loss: Grade B. Di Minno and colleagues followed 126 overweight or obese PsA patients starting TNF blockers. Those on a structured hypocaloric diet reached minimal disease activity more often than those on a free diet (HR 1.85), and losing 5% or more of body weight predicted minimal disease activity regardless of diet type (Di Minno et al., 2014). In Klingberg's open study of 41 PsA patients with a BMI of 33 or higher, a 640 kcal/day formula diet for 12 to 16 weeks produced a median loss of 18.7 kg; the share of patients in minimal disease activity rose from 29.3% to 53.7% at six months (Klingberg et al., 2019).

Omega-3: Grade B. In a 24-week double-blind trial of 145 PsA patients, 3 g of marine omega-3 daily did not significantly beat olive oil on DAS28-CRP, but it cut NSAID and paracetamol use (p = 0.04) and lowered leukotriene B4 formation (Kristensen et al., 2018). Skin-focused advice is in our psoriasis diet and natural treatment guide.

IBD-Associated Arthritis

When spondyloarthritis rides alongside Crohn's disease or ulcerative colitis, the diet should be built for the bowel first. Controlling gut inflammation usually helps the joints too, and many biologics treat both. Use our Crohn's disease supplements guide and ulcerative colitis supplements guide for the gut-specific evidence, and do not start a restrictive diet during a flare without your gastroenterologist.

Reactive Arthritis: Food Safety Is the Diet

Reactive arthritis is the one HLA-B27 condition with a clear food link, and the link is infection. Townes and colleagues tracked 6,379 culture-confirmed Campylobacter, E. coli O157, Salmonella, Shigella and Yersinia infections in Minnesota and Oregon. Of those screened, 575 (13%) developed possible reactive arthritis, most often after Campylobacter and Salmonella (Townes et al., 2008).

One detail surprises most readers. In that population-based study, risk was not associated with HLA-B27; women, adults and people with severe acute illness were at higher risk. Hospital series report higher HLA-B27 rates, likely because B27 carriers get more severe or chronic disease. Grade B for food safety as prevention: the trigger is established, though no trial has tested hygiene advice in carriers.

Anterior Uveitis

No dietary study has targeted HLA-B27 uveitis. Treatment is eye drops, sometimes injections or biologics, under an ophthalmologist. The general spondyloarthritis advice applies, nothing more.

HLA-B27 Positive Diet Chart (Printable)

Use this chart if you have a diagnosed HLA-B27 associated condition. Each row shows who it applies to and how strong the evidence is. Print it or save it as a PDF and bring it to your next rheumatology or dietitian visit.

Two practical notes. First, the "situational" rows exist because blanket elimination costs nutrients and quality of life for no proven gain. Dairy is a good example: in an open 1994 study of 25 AS patients, 52% reported benefit at six weeks, but only 24% were still on the diet at two years (Appelboom and Durez, 1994, as summarized in Popa et al., 2022). If you remove dairy, replace the calcium, because AS already raises osteoporosis risk.

Second, gluten. Our article on gluten and joint inflammation covers the pathways. For HLA-B27 disease specifically, no trial supports going gluten-free unless you have celiac disease, so test first.

How to Run a Personal Food Trial

1. Keep a two-week baseline diary: morning stiffness minutes, night pain (0–10), fatigue (0–10) and bowel symptoms.
2. Change one thing only, such as cutting starch or adding fish three times a week.
3. Hold the change for 6 to 8 weeks. Spondyloarthritis symptoms swing on their own, and shorter trials mislead.
4. Compare diary averages and, if your doctor agrees, a repeat CRP.
5. Keep what clearly helped. Drop what did not. Then test the next item.

Should HLA-B27 Positive People Go Low-Starch?

This is the most searched HLA-B27 diet question, and the answer depends on whether you have disease.

With active AS or axSpA, a low-starch trial is reasonable. The mechanism is plausible, the downside is modest when vegetables, protein and healthy fats replace the starch, and some patients report clear relief. The single supporting clinical study is uncontrolled, so the grade stays C.

Without disease, there is no case for it. No study has followed healthy HLA-B27 carriers on low-starch diets to see whether fewer of them develop AS. Cutting a whole food group for a 1-in-100 risk, with no evidence that it lowers that risk, trades known costs for an unproven gain. Our London diet deep-dive lays out the full low-starch protocol for those who want to try it.

HLA-B27 Positive Without Disease: Do You Need a Diet?

Many readers land here after a blood test ordered for back pain, eye trouble or a family history, and the result came back positive with no diagnosis attached. For you, the evidence points in one direction: there is no HLA-B27 prevention diet.

No trial has tested any diet for preventing spondyloarthritis in carriers. The VITAL trial found that vitamin D3 supplementation reduced overall autoimmune disease incidence by 22% in older adults, but it did not test HLA-B27 carriers or report spondyloarthritis separately. Sensible general eating, a healthy weight, not smoking and regular exercise are good for everyone and carry no downside.

What deserves your attention are the warning signs. See a doctor, ideally a rheumatologist, if you notice:

• Back pain that started before age 45, has lasted more than three months, wakes you in the second half of the night and improves with movement rather than rest
• Morning stiffness lasting more than 30 minutes
• Alternating buttock pain
• A swollen finger or toe, or heel pain without injury
• Joint pain within weeks of food poisoning or a sexually transmitted infection
• A red, painful, light-sensitive eye (same-day eye exam)

Early diagnosis matters. Modern biologics work, and diagnostic delays in axial spondyloarthritis have historically run for years.

Diet, Medications and Safety

Diet changes interact with the drugs most HLA-B27 patients take. Discuss each of these with your doctor before you start.

• NSAIDs (naproxen, ibuprofen, celecoxib, diclofenac). Regular alcohol on top of daily NSAIDs raises the risk of stomach bleeding. Take NSAIDs with food.
• Methotrexate (common in PsA). Alcohol and methotrexate together stress the liver. Follow your prescriber's alcohol limit and keep taking the prescribed folic acid.
• Biologics (TNF, IL-17 and IL-23 inhibitors) and JAK inhibitors. These raise infection risk, and TNF inhibitor labeling lists serious infections including Listeria. Avoid unpasteurized dairy, raw sprouts, undercooked meat and eggs, and deli meats that are not reheated until steaming.
• Omega-3 at 3 g a day or more. Fish oil can add to the bleeding effect of anticoagulants and antiplatelet drugs. Check with your doctor if you take warfarin, a DOAC, clopidogrel or daily aspirin.
• Very low energy diets. Formula diets near 640 kcal/day, as in the Klingberg study, were run under medical supervision. Do not attempt one alone, especially with diabetes medication or blood pressure drugs that may need adjusting.
• Restrictive diets during IBD flares. These can worsen malnutrition. Involve your gastroenterologist or an IBD dietitian.

Never stop or reduce a prescribed medication because a diet seems to be working. Talk with your rheumatologist first; tapering is a medical decision based on exam findings, labs and imaging.

Frequently Asked Questions

Is there a specific diet for HLA-B27 positive people?

No diet changes what the gene does. With a diagnosed spondyloarthritis, the best-supported steps are reaching a healthy weight (Grade B), omega-3 from fish or supplements (Grade B) and a Mediterranean, fiber-rich pattern (Grade C). Without symptoms, a normal healthy diet is enough.

Should I avoid starch if I am HLA-B27 positive?

Only if you have active AS or axSpA and want to test it for 6 to 8 weeks with a symptom diary. The evidence is one uncontrolled study of 36 patients. Healthy carriers have no reason to cut starch.

What foods trigger HLA-B27 flares?

No food reliably triggers flares across HLA-B27 diseases. In a Swedish cohort, 27% of AS patients reported that certain foods worsened gut symptoms, but diet showed no link to disease activity (Sundström et al., 2011). The clearest food trigger is food poisoning, which can set off reactive arthritis.

Can diet prevent ankylosing spondylitis if I carry HLA-B27?

No study shows it. About 1.3% of HLA-B27 positive adults in the general population develop AS. With an affected first-degree relative, the figure rose to about 27% over 35 years in one Swiss family study. Early recognition of symptoms matters more than diet.

Is the Mediterranean diet good for axial spondyloarthritis?

It is the most reasonable default. In 161 axSpA patients, better Mediterranean adherence was associated with a 20% or greater drop in ASDAS-CRP (Ometto et al., 2021). The data are observational, so the grade is C, but the pattern also lowers cardiovascular risk.

Does weight loss help HLA-B27 related arthritis?

Yes, most clearly in psoriatic arthritis. Losing 5% or more of body weight predicted minimal disease activity in PsA patients on TNF blockers (Di Minno et al., 2014). In AS, higher BMI predicted a weaker infliximab response (Ottaviani et al., 2012).

Build Your Personal Protocol

An HLA-B27 result is one piece of your picture. Your condition, medications, weight, gut symptoms and labs decide which items on the chart deserve your effort first. For the broader menu of anti-inflammatory approaches, see our autoimmune diet comparison, and for gut-focused support, our guides to probiotics for autoimmune disease and the leaky gut protocol.

Take the free 3-minute quiz to find your personalized protocol. It maps your condition, severity and current treatment to evidence-graded diet, supplement and lifestyle steps you can discuss with your doctor.

References

• Asquith M, et al. (2019). HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome. Arthritis & Rheumatology, 71(10), 1642–1650.
• Baeten D, et al. (2015). Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. New England Journal of Medicine, 373(26), 2534–2548.
• Braun J, et al. (1998). Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis & Rheumatism, 41(1), 58–67.
• Ciccia F, et al. (2014). Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Annals of the Rheumatic Diseases, 73(8), 1566–1574.
• Colbert RA, DeLay ML, Layh-Schmitt G, Sowders DP. (2009). HLA-B27 misfolding and spondyloarthropathies. Advances in Experimental Medicine and Biology, 649, 217–234.
• Costello ME, et al. (2015). Brief report: intestinal dysbiosis in ankylosing spondylitis. Arthritis & Rheumatology, 67(3), 686–691.
• DeLay ML, et al. (2009). HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism, 60(9), 2633–2643.
• Di Minno MN, et al. (2014). Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Annals of the Rheumatic Diseases, 73(6), 1157–1162.
• Ebringer A, Wilson C. (1996). The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis. Clinical Rheumatology, 15(Suppl 1), 62–66.
• Gwinnutt JM, et al. (2023). 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases, 82(1), 48–56.
• Hammer RE, et al. (1990). Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m. Cell, 63(5), 1099–1112.
• Klingberg E, et al. (2019). Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study. Arthritis Research & Therapy, 21, 17.
• Kristensen S, et al. (2018). Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo-controlled trial. Scandinavian Journal of Rheumatology, 47(1), 27–36.
• Macfarlane TV, et al. (2018). Relationship between diet and ankylosing spondylitis: a systematic review. European Journal of Rheumatology, 5(1), 45–52.
• Ometto F, et al. (2021). Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort. Arthritis Research & Therapy, 23, 219.
• Ottaviani S, et al. (2012). Body mass index influences the response to infliximab in ankylosing spondylitis. Arthritis Research & Therapy, 14(3), R115.
• Popa SL, et al. (2022). Nutrition in spondyloarthritis and related immune-mediated disorders. Nutrients, 14(6), 1278.
• Reveille JD, Hirsch R, Dillon CF, Carroll MD, Weisman MH. (2012). The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009. Arthritis & Rheumatism, 64(5), 1407–1411.
• Song C, et al. (2023). Dietary fiber intake influences changes in ankylosing spondylitis disease status. Journal of Clinical Medicine, 12(4), 1621.
• Sundström B, et al. (2006). Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis. Scandinavian Journal of Rheumatology, 35(5), 359–362.
• Sundström B, Wållberg-Jonsson S, Johansson G. (2011). Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis. Clinical Rheumatology, 30(1), 71–76.
• Taurog JD, et al. (1994). The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. Journal of Experimental Medicine, 180(6), 2359–2364.
• Townes JM, et al. (2008). Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Annals of the Rheumatic Diseases, 67(12), 1689–1696.
• Van den Bruel K, Kulyk M, Neerinckx B, De Vlam K. (2025). Nutrition and diet in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: a systematic review. Frontiers in Medicine, 12.
• van der Linden SM, et al. (2022). Recurrence of axial spondyloarthritis among first-degree relatives in a prospective 35-year-follow-up family study. RMD Open, 8(2), e002208.
• Wakefield D, Clarke D, McCluskey P. (2020). Recent developments in HLA B27 anterior uveitis. Frontiers in Immunology, 11, 608134.

This site provides educational information only. Not medical advice. Always consult your healthcare provider before changing your treatment plan. Evidence grades reflect our assessment of the current literature and are meant to support informed conversations with your rheumatologist, gastroenterologist or ophthalmologist. Do not stop or reduce prescribed medication without medical guidance.